nuclear medicine

Search documents
BWX Technologies(BWXT) - 2025 Q1 - Earnings Call Presentation
2025-05-06 02:22
Financial Performance - Q1 2025 - Revenue increased by 13%, driven by organic growth in both Government Operations and Commercial Operations[7, 9, 10] - Adjusted EBITDA increased by 13%, and Non-GAAP EPS increased by 20% due to higher operating earnings and a lower tax rate[7, 10] - Free Cash Flow was $17 million in 1Q25[10] Segment Performance - Q1 2025 - Government Operations revenue grew by 14% (13% organic), leading to an adjusted EBITDA margin of 21.1%[7] - Commercial Operations revenue grew by 10%, driven by double-digit medical growth and solid commercial power growth[7] Backlog and Acquisitions - Commercial Operations backlog increased by 39% Q/Q and 78% Y/Y to $1.3 billion, mainly due to the Pickering Life Extension steam generator contract[7] - The acquisition of Kinectrics, Inc, is expected to close mid-year, enhancing service offerings to nuclear power and medical markets[7] 2025 Outlook - The company reaffirms its 2025 Adjusted EPS guidance of $3.40-$3.55[6] - Revenue is projected to be approximately $3.0 billion, with growth in both Government and Commercial Operations[7, 17] - Adjusted EBITDA is expected to be between $550 million and $570 million, including contributions from AOT and the pending Kinectrics acquisition[7, 17]